These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16619394)

  • 1. Visceral hypersensitivity in irritable bowel syndrome: a summary review.
    Stacher G; Christensen J
    Dig Dis Sci; 2006 Mar; 51(3):440-5. PubMed ID: 16619394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
    Camilleri M; Lasch K; Zhou W
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in role of estrogens in visceral hypersensitivity of IBS].
    Dong X; Chen SL
    Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):362-4. PubMed ID: 21416927
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders.
    Faure C; Wieckowska A
    J Pediatr; 2007 Jan; 150(1):66-71. PubMed ID: 17188617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome.
    Wilder-Smith CH; Robert-Yap J
    World J Gastroenterol; 2007 Jul; 13(27):3699-704. PubMed ID: 17659729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome.
    Delvaux M
    Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i67-71. PubMed ID: 12077070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visceral hypersensitivity of the large intestine mucosa in patients with irritable bowel syndrome--cause of the non-inflammatory changes in the pain syndrome].
    Zhukov NA; Sorokina EA; Akhmedov VA; Kopeĭkin SA; Pavlov AV; Tuleeva NK; Lazeeva TL; Ereshchenko KIu
    Eksp Klin Gastroenterol; 2003; (5):75-8, 195. PubMed ID: 14621617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome.
    Keszthelyi D; Troost FJ; Masclee AA
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(2):G141-54. PubMed ID: 22595988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral afferent hypersensitivity in irritable bowel syndrome--evaluation by cerebral evoked potential after rectal stimulation.
    Sinhamahapatra P; Saha SP; Chowdhury A; Chakrabarti SK; Ghosh A; Maiti B
    Am J Gastroenterol; 2001 Jul; 96(7):2150-7. PubMed ID: 11467647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional gastrointestinal disorders and visceral hypersensitivity in children and adolescents suffering from Crohn's disease.
    Faure C; Giguère L
    Inflamm Bowel Dis; 2008 Nov; 14(11):1569-74. PubMed ID: 18521915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitisation of gastrointestinal tract afferents.
    McMahon SB
    Gut; 2004 Mar; 53 Suppl 2(Suppl 2):ii13-5. PubMed ID: 14960552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders?
    Castilloux J; Noble A; Faure C
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):272-8. PubMed ID: 18376243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal forebrain activity in functional bowel disorder patients with chronic pain.
    Kwan CL; Diamant NE; Pope G; Mikula K; Mikulis DJ; Davis KD
    Neurology; 2005 Oct; 65(8):1268-77. PubMed ID: 16247056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome.
    Barbara G; Cremon C; De Giorgio R; Dothel G; Zecchi L; Bellacosa L; Carini G; Stanghellini V; Corinaldesi R
    Curr Gastroenterol Rep; 2011 Aug; 13(4):308-15. PubMed ID: 21537962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents.
    Akbar A; Walters JR; Ghosh S
    Aliment Pharmacol Ther; 2009 Sep; 30(5):423-35. PubMed ID: 19493256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal sensory threshold for pain is a diagnostic marker of irritable bowel syndrome and functional abdominal pain in children.
    Halac U; Noble A; Faure C
    J Pediatr; 2010 Jan; 156(1):60-65.e1. PubMed ID: 19800076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrarectal lidocaine is an effective treatment for abdominal pain associated with diarrhea-predominant irritable bowel syndrome.
    Verne GN; Sen A; Price DD
    J Pain; 2005 Aug; 6(8):493-6. PubMed ID: 16084463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-inflammatory modification of colonic afferent mechanosensitivity.
    Hughes PA; Brierley SM; Blackshaw LA
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):1034-40. PubMed ID: 19566823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.
    Kuiken SD; Lindeboom R; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Jul; 22(2):157-64. PubMed ID: 16011674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model.
    Chen BR; Du LJ; He HQ; Kim JJ; Zhao Y; Zhang YW; Luo L; Dai N
    World J Gastroenterol; 2017 Dec; 23(47):8321-8333. PubMed ID: 29307992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.